| MR编号 | NL/H/4067/007 |
|---|
| 药品名称 | Lenalidomide Teva 25 mg, harde capsules |
|---|
| 活性成分 | - lenalidomide hydrochloride 25.0 mg
|
|---|
| 剂型 | Capsule, hard |
|---|
| 上市许可持有人 | Teva B.V.
the Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Lenalidomide Teva 25 mg, harde capsules |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
Lenalidomid-ratiopharm 25 mg Hartkapseln - Denmark (DK)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Lenalidomid TEVA 25 mg Hartkapseln - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Lenalidomide Teva - Finland (FI)
- Hungary (HU)
LENALIDOMID TEVA 25 mg kemény kapszula - Czechia (CZ)
Lenalidomid Teva - Slovakia (SK)
Lenalidomid Teva B.V. 25 mg - Slovenia (SI)
Lenalidomid Teva 25 mg trde kapsule - Croatia (HR)
Lenalidomid Teva 25 mg tvrde kapsule - Iceland (IS)
|
|---|
| 许可日期 | 2018/07/12 |
|---|
| 最近更新日期 | 2025/09/11 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|